BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.42
+0.12 (1.64%)
Nov 21, 2024, 1:44 PM EST - Market open

BioCryst Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for BCRX stock have an average target of 15.6, with a low estimate of 8.00 and a high estimate of 30. The average target predicts an increase of 110.24% from the current stock price of 7.42.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $15.6 $14 $30
Change +7.82% +110.24% +88.68% +304.31%

Analyst Ratings

The average analyst rating for BCRX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 442222
Buy 333332
Hold 001111
Sell 000000
Strong Sell 000000
Total 776665

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Reiterates
$10
Buy Reiterates $10 +34.77% Nov 5, 2024
Needham
Needham
Strong Buy
Reiterates
$14
Strong Buy Reiterates $14 +88.68% Nov 5, 2024
Barclays
Barclays
Hold
Maintains
$7$8
Hold Maintains $7$8 +7.82% Nov 5, 2024
JMP Securities
JMP Securities
Buy
Maintains
$15$16
Buy Maintains $15$16 +115.63% Aug 6, 2024
Barclays
Barclays
Hold
Maintains
$6$7
Hold Maintains $6$7 -5.66% Aug 6, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
454.83M
from 331.41M
Increased by 37.24%
Revenue Next Year
542.60M
from 454.83M
Increased by 19.30%
EPS This Year
-0.38
from -1.18
EPS Next Year
-0.06
from -0.38
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
48.84M17.81M157.17M270.83M331.41M454.83M542.60M626.29M
Revenue Growth
136.45%-63.53%782.38%72.31%22.37%37.24%19.30%15.42%
EPS
-0.94-1.09-1.03-1.33-1.18-0.38-0.060.28
EPS Growth
--------
Forward PE
-------26.59
No. Analysts -----131311
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 476.7M 577.5M 697.7M
Avg 454.8M 542.6M 626.3M
Low 421.8M 496.2M 553.7M

Revenue Growth

Revenue Growth 20242025202620272028
High
43.8%
27.0%
28.6%
Avg
37.2%
19.3%
15.4%
Low
27.3%
9.1%
2.0%

EPS Forecast

EPS 20242025202620272028
High -0.32 0.12 0.57
Avg -0.38 -0.06 0.28
Low -0.45 -0.23 -0.07

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.